中文产业新闻精选评分78Chinese source
恒瑞HER2 ADC瑞康曲妥珠单抗获NMPA批准，用于HER2阳性结直肠癌后线治疗
国内首个！恒瑞单抗获批新适应症
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
国内首个！恒瑞单抗获批新适应症
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.